24.2 C
New York
Thursday, June 11, 2026

Tag: healthcare solutions

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven...

Patients in the IMAAVY 30 mg/kg treatment groupa achieved statistically significant durable hemoglobin responseb, with mean hemoglobin improvement of at least 1 g/dL as...

CAREstream America introduces new era of science-backed innovation to deliver a new standard of quality to the US aesthetic market

CAREstream America announces an exclusive distribution partnership to bring Celltermi HS and NX Plus, an advanced probiotic-derived microbiome technology, to the US market. Celltermi...

Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference

Fangzhou showcased its “AI + Chronic Disease Services” digital solution developed in collaboration with Tencent Health.

TelkomMetra Strengthens Its Business Portfolio Restructuring Strategy, AdMedika Group Ready for Distinct Expansion under Fullerton Health

This strategic initiative aligns with Danantara Indonesia's streamlining directive to TelkomGroup in strengthening its structure and sharpening its business focus.JAKARTA, Indonesia, June 4, 2026...

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and...

Home Control International Limited (Stock Code: 1747.HK) Announces 2025 Interim Results

Net Profit Increased by 56.9% Year-on-year to US$5.0 million Strategic Pursuit of Growth: Venturing into the Home Healthcare Sector Financial Highlights For the six months ended 30...

Consolidated Interim Report 1 January – 30 June 2025

Consolidated Interim Report 1 January – 30 June 2025
Key points from the H1-2025 report (period 1 January - 30 June 2025)

Shilpa Medicare’s NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a billion people affected by Non-Alcoholic Fatty...

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new...

HopeAI Joins Mayo Clinic Platform to Transform the Future of Drug Development with AI

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- HopeAI, an emerging leader in applying artificial intelligence (AI) to accelerate new drug development, has officially joined...

Global Digital Health Market Poised for Robust Growth at a CAGR of ~18% by 2032 Amid Rising Demand for Remote Care| DelveInsight

The digital health market is experiencing robust growth, driven by increasing adoption of telemedicine, wearable devices, and AI-powered health solutions. Rising healthcare costs and...

Philippines’ AC Health partners with Singapore’s ABC Impact in vision to transform health for every Filipino

MANILA, Philippines, Aug. 11, 2025 /PRNewswire/ -- AC Health, the healthcare arm of Ayala Corporation, has secured a landmark investment from ABC Impact, the...

- A word from our sponsors -

spot_img
HomeTagsHealthcare solutions